Mortality in sepsis and septic shock in Europe, North America and Australia between 2009 and 2019- results from a systematic review and meta-analysis.
Meta-analysis
Mortality
SOFA
Sepsis
Septic shock
Trend
Journal
Critical care (London, England)
ISSN: 1466-609X
Titre abrégé: Crit Care
Pays: England
ID NLM: 9801902
Informations de publication
Date de publication:
19 05 2020
19 05 2020
Historique:
received:
28
01
2020
accepted:
07
05
2020
entrez:
21
5
2020
pubmed:
21
5
2020
medline:
14
1
2021
Statut:
epublish
Résumé
Sepsis and septic shock remain drivers for mortality in critically ill patients. The heterogeneity of the syndrome hinders the generation of reproducible numbers on mortality risks. Consequently, mortality rates range from 15 to 56%. We aimed to update and extend the existing knowledge from meta-analyses and estimate 30- and 90-day mortality rates for sepsis and septic shock separately, stratify rates by region and study type and assess mortality rates across different sequential organ failure assessment (SOFA) scores. We performed a systematic review of articles published in PubMed or in the Cochrane Database, between 2009 and 2019 in English language including interventional and observational studies. A meta-analysis of pooled 28/30- and 90-day mortality rated separately for sepsis and septic shock was done using a random-effects model. Time trends were assessed via Joinpoint methodology and for the assessment of mortality rate over different SOFA scores, and linear regression was applied. Four thousand five hundred records were identified. After title/abstract screening, 783 articles were assessed in full text for eligibility. Of those, 170 studies were included. Average 30-day septic shock mortality was 34.7% (95% CI 32.6-36.9%), and 90-day septic shock mortality was 38.5% (95% CI 35.4-41.5%). Average 30-day sepsis mortality was 24.4% (95% CI 21.5-27.2%), and 90-day sepsis mortality was 32.2% (95% CI 27.0-37.5%). Estimated mortality rates from RCTs were below prospective and retrospective cohort studies. Rates varied between regions, with 30-day septic shock mortality being 33.7% (95% CI 31.5-35.9) in North America, 32.5% (95% CI 31.7-33.3) in Europe and 26.4% (95% CI 18.1-34.6) in Australia. A statistically significant decrease of 30-day septic shock mortality rate was found between 2009 and 2011, but not after 2011. Per 1-point increase of the average SOFA score, average mortality increased by 1.8-3.3%. Trends of lower sepsis and continuous septic shock mortality rates over time and regional disparities indicate a remaining unmet need for improving sepsis management. Further research is needed to investigate how trends in the burden of disease influence mortality rates in sepsis and septic shock at 30- and 90-day mortality over time.
Sections du résumé
BACKGROUND
Sepsis and septic shock remain drivers for mortality in critically ill patients. The heterogeneity of the syndrome hinders the generation of reproducible numbers on mortality risks. Consequently, mortality rates range from 15 to 56%. We aimed to update and extend the existing knowledge from meta-analyses and estimate 30- and 90-day mortality rates for sepsis and septic shock separately, stratify rates by region and study type and assess mortality rates across different sequential organ failure assessment (SOFA) scores.
METHODS
We performed a systematic review of articles published in PubMed or in the Cochrane Database, between 2009 and 2019 in English language including interventional and observational studies. A meta-analysis of pooled 28/30- and 90-day mortality rated separately for sepsis and septic shock was done using a random-effects model. Time trends were assessed via Joinpoint methodology and for the assessment of mortality rate over different SOFA scores, and linear regression was applied.
RESULTS
Four thousand five hundred records were identified. After title/abstract screening, 783 articles were assessed in full text for eligibility. Of those, 170 studies were included. Average 30-day septic shock mortality was 34.7% (95% CI 32.6-36.9%), and 90-day septic shock mortality was 38.5% (95% CI 35.4-41.5%). Average 30-day sepsis mortality was 24.4% (95% CI 21.5-27.2%), and 90-day sepsis mortality was 32.2% (95% CI 27.0-37.5%). Estimated mortality rates from RCTs were below prospective and retrospective cohort studies. Rates varied between regions, with 30-day septic shock mortality being 33.7% (95% CI 31.5-35.9) in North America, 32.5% (95% CI 31.7-33.3) in Europe and 26.4% (95% CI 18.1-34.6) in Australia. A statistically significant decrease of 30-day septic shock mortality rate was found between 2009 and 2011, but not after 2011. Per 1-point increase of the average SOFA score, average mortality increased by 1.8-3.3%.
CONCLUSION
Trends of lower sepsis and continuous septic shock mortality rates over time and regional disparities indicate a remaining unmet need for improving sepsis management. Further research is needed to investigate how trends in the burden of disease influence mortality rates in sepsis and septic shock at 30- and 90-day mortality over time.
Identifiants
pubmed: 32430052
doi: 10.1186/s13054-020-02950-2
pii: 10.1186/s13054-020-02950-2
pmc: PMC7236499
doi:
Types de publication
Journal Article
Meta-Analysis
Research Support, Non-U.S. Gov't
Systematic Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
239Références
JAMA. 2016 Feb 23;315(8):801-10
pubmed: 26903338
JAMA. 2014 Apr 2;311(13):1308-16
pubmed: 24638143
N Engl J Med. 2018 Mar 01;378(9):797-808
pubmed: 29347874
Br J Anaesth. 2017 Oct 1;119(4):626-636
pubmed: 29121281
Stat Med. 2000 Feb 15;19(3):335-51
pubmed: 10649300
Crit Care Med. 2013 May;41(5):1167-74
pubmed: 23442987
Crit Care. 2018 Mar 21;22(1):79
pubmed: 29562917
BMJ. 2019 Aug 28;366:l4898
pubmed: 31462531
Syst Rev. 2016 Dec 13;5(1):212
pubmed: 27964742
Intensive Care Med. 2016 Dec;42(12):1912-1921
pubmed: 27448676
Crit Care Med. 2014 Mar;42(3):625-31
pubmed: 24201173
Crit Care Med. 2017 Mar;45(3):486-552
pubmed: 28098591
JAMA Pediatr. 2019 Apr 1;173(4):352-362
pubmed: 30742207
Chest. 2019 Jan;155(1):12-14
pubmed: 30616719
N Engl J Med. 2013 Aug 29;369(9):840-51
pubmed: 23984731
BMJ. 2016 Oct 12;355:i4919
pubmed: 27733354
N Engl J Med. 2014 Oct 16;371(16):1496-506
pubmed: 25272316
JAMA. 2017 Oct 3;318(13):1241-1249
pubmed: 28903154
Ann Am Thorac Soc. 2017 Feb;14(2):230-237
pubmed: 27854510
Intensive Care Med. 2013 Feb;39(2):165-228
pubmed: 23361625
JAMA. 2016 Feb 23;315(8):775-87
pubmed: 26903336
Chest. 1992 Jun;101(6):1644-55
pubmed: 1303622
Crit Care. 2019 Jul 3;23(1):241
pubmed: 31269976
BMJ. 2009 Jul 21;339:b2535
pubmed: 19622551
BMJ. 2016 May 17;353:i2375
pubmed: 27189000
J Crit Care. 2017 Oct;41:78-85
pubmed: 28500919
JAMA. 2016 Feb 23;315(8):762-74
pubmed: 26903335
Crit Care. 2019 May 31;23(1):196
pubmed: 31151462